The National Institute on Alcohol Abuse and Alcoholism awarded San Diego State University Foundation $483,653 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate the effects of prenatal alcohol and cannabis exposure on vulnerability to later drug use disorders. The project uses a rodent model of prenatal alcohol, THC, or combined exposure via vapor inhalation to identify whether prenatal exposure causes long-lasting alterations in anxiety-like behaviors,...
The National Institute on Drug Abuse awarded the University of Southern California $2.251 million on April 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and pilot-test a brief mobile phone-based intervention addressing prenatal cannabis use. The intervention incorporates motivational enhancement messaging to correct misperceptions about cannabis harms during pregnancy, alongside harm-reduction and cognitive-behavioral skills—including protective...
The National Institute on Alcohol Abuse and Alcoholism awarded Trustees of Indiana University, doing business as Indiana University Indianapolis, $381,363 on August 20, 2026, under the Alcohol Research Programs (CFDA 93.273) to support research on inhibitory corticostriatal circuit mechanisms underlying binge alcohol drinking. The award funds investigation of how alcohol alters synaptic function in neural circuits that contribute to alcohol use disorder progression, specifically focusing on...
The National Institute on Drug Abuse awarded Trustees of Boston College (Boston College) $155,000 on May 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279), a Project Grant supporting research on the effects of recreational cannabis legalization on disparities in prenatal substance use. The research examines how state recreational cannabis laws affect women's use of cannabis, tobacco, and alcohol during pregnancy, preconception, and postpartum periods, as well as health...
The National Institute on Drug Abuse awarded the University of Southern California $149,766 on August 12, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate simultaneous nicotine, alcohol, and cannabis co-use among young adults. The funded research examines patterns of use, subjective experiences, and consequences of simultaneous substance co-use—defined as using multiple substances close in time so their effects overlap—among approximately 3,860 young adults...
The National Institute on Alcohol Abuse and Alcoholism awarded Trustees of Indiana University (Indiana University Indianapolis) $138,118 on March 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to conduct an integrative multi-omics study identifying cell-type and brain-region specific genetic drivers of alcohol use disorder. The recipient will perform differential expression and chromatin accessibility analyses using single-nucleus RNA-seq and ATAC-seq data from four brain regions...
The National Institute on Alcohol Abuse and Alcoholism, part of the Department of Health and Human Services National Institutes of Health, awarded $702,720 to Indiana University Indianapolis on August 10, 2026, under the Alcohol Research Programs (CFDA 93.273) project grant R01AA031671. The award funds research investigating posterior default mode network modulation as a treatment target in alcohol use disorder. The research examines how dysfunction in the medial posterior default mode...
The National Institute on Drug Abuse awarded the University of Washington $699,748 on February 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal neuroimaging and neurobehavioral assessment of infants prenatally exposed to cannabis. The research characterizes neurodevelopmental trajectories and brain changes associated with prenatal cannabis exposure during the critical first 18 months of life, when rapid synaptogenesis, axonal growth, and...
The National Institute on Alcohol Abuse and Alcoholism awarded the Trustees of Indiana University (Indiana University Indianapolis) $163,824 on May 4, 2026, under the Alcohol Research Programs (CFDA 93.273) as a Project Grant (K08 award K08AA032351). The award funds research and training on intergenerational trauma and youth alcohol use, specifically examining how maternal post-traumatic stress disorder affects youth neurobiology and alcohol consumption. The principal investigator will acquire...
The National Institute on Drug Abuse, a component of the Department of Health and Human Services National Institutes of Health, awarded $703,662 to The Regents Of The University Of Colorado (doing business as University Of Colorado-Denver) on July 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to investigate prenatal cannabis exposure and child growth through examination of angiogenic and adipogenic pathways in perinatal tissues. The research combines large-scale...
The National Institute on Drug Abuse awarded $1.343 million to the Trustees of Indiana University on August 1, 2026, for a prospective study of alcohol and cannabis use across perinatal transitions under the Drug Use and Addiction Research Programs (CFDA 93.279).
The study examines longitudinal and proximal antecedents of prenatal cannabis use and postpartum alcohol use among women who are heavy drinkers, with particular attention to behavioral factors such as motives and intentions. The research addresses rising alcohol-related mortality among women and evidence that alcohol and cannabis co-use is associated with heavier alcohol consumption and greater alcohol-related problems. The project represents a comprehensive examination of perinatal alcohol and cannabis co-use trajectories, including analysis of how pre-pregnancy heavy drinking predicts cannabis substitution during pregnancy and postpartum drinking patterns.
Work is performed at Indiana University Indianapolis, Indianapolis, Indiana. The period of performance runs through May 31, 2031. The assistance type is a Project Grant.